Ren Wang

Ms. Ren Wang

Agricultural, life and environmental science, University of Alberta, Edmonton, Alberta, Canada
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2023 in Applied Physiology, Nutrition, and Metabolism
Verified
Journal Article
Closed access
DPDhruvesh Patel
Dhruvesh Patel
JEJenna Evanchuk
Jenna Evanchuk
RWRen Wang
Ren Wang
CDCarolyn L. Dunbar
Carolyn L. Dunbar
JMJaqueline Munhoz
Jaqueline Munhoz
CFCatherine Field
Catherine Field
The immune system requires an adequate supply of nutrients, although current dietary recommendations may not account for optimal immune function in healthy adults. Nutrient inadequacies due to the growing influence of the western diet pose a risk for immune dysfunction. This review aims to determine the beneficial effects of supplementing dietary fats, nutrients that modulate gut microbiota, and specific micronutrients on systemic immune functions (concentrations of plasma cytokines, antibodies, and acute phase proteins) during health and acute inflammatory conditions, including COVID-19. We discussed micronutrients (selenium, zinc, and vitamin D) with compelling evidence supporting immunomodulatory properties. Additionally, the synergistic effects of physical activity and dietary interventions on systemic immune markers are explored. Briefly, evidence suggests that dietary consumption of monounsaturated (oleic and palmitoleic acids) and omega-3 polyunsaturated fatty acids (eicosapentaenoic and docosahexaenoic acids) promotes anti-inflammatory properties. Food sources (fiber, prebiotics, probiotics, omega-3) and patterns (Mediterranean diet) increase the production of short-chain fatty acids, beneficially altering gut microbiota composition, which subsequently enhances the immunomodulatory properties of circulating immune cells. A positive synergistic role of nutrient supplementation (omega-3 and fiber) and physical activity on circulating C-reactive protein and interleukin-6 levels has been observed. Lastly, omega-3 supplementation during COVID-19 infection may reduce circulating C-reactive protein and pro-inflammatory cytokines and improves pain and fatigue symptoms. This review highlights recent findings that support the beneficial role of specific nutrients in promoting systemic immune function in healthy adults. However, to establish specific dietary recommendations to support optimal immune function, more research is required. Key takeaway: Increasing dietary fats (fish and olive oils) and specific micronutrients may positively impact systemic immune function in healthy adults. Evidence suggests that these nutrients promote immunomodulatory properties useful in resolving acute infection.

24 January 2023 in Metabolites
Verified
Journal Article
Open access
PDF file
SZStepheny Carneiro de Campos Zani
Stepheny Carneiro de Campos Zani
RWRen Wang
Ren Wang
HVHellen Veida-Silva
Hellen Veida-Silva
RCRobin Clugston
Robin Clugston
JYJessica T. Y. Yue
Jessica T. Y. Yue
Catherine ChanCatherine Chan
Catherine Chan
Non-alcoholic fatty liver disease (NAFLD), the hepatic manifestation of the metabolic syndrome, is a global health problem. Currently, no pharmacological treatment is approved for NAFLD. Natural health products, including bioactive peptides, are potential candidates to aid in the management of metabolic syndrome-related conditions, including insulin resistance and obesity. In this study, we hypothesized that an egg-white-derived bioactive peptide QAMPFRVTEQE (Peptide 2) would improve systemic and local white adipose tissue insulin sensitivity, thereby preventing high-fat diet-induced exacerbation of pathological features associated with NAFLD, such as lipid droplet size and number, inflammation, and hepatocyte hypertrophy in high-fat diet-fed mice. Similar to rosiglitazone, Peptide 2 supplementation improved systemic insulin resistance during the hyperinsulinemic-euglycemic clamp and enhanced insulin signalling in white adipose tissue, modulating ex vivo lipolysis. In the liver, compared with high-fat diet fed animals, Peptide 2 supplemented animals presented decreased hepatic cholesterol accumulation (p < 0.05) and area of individual hepatic lipid droplet by around 50% (p = 0.09) and reduced hepatic inflammatory infiltration (p < 0.05) whereas rosiglitazone exacerbated steatosis. In conclusion, Peptide 2 supplementation improved insulin sensitivity and decreased hepatic steatosis, unlike the insulin-sensitizing drug rosiglitazone.

15 July 2020 in Inflammation Research
Verified
Journal Article
Closed access
PDF file
QLQin Li
Qin Li
YWYinfan Wu
Yinfan Wu
XGXingyue Guo
Xingyue Guo
RWRen Wang
Ren Wang
YMYuheng Mao
Yuheng Mao
YYYan Yang
Yan Yang

21 January 2026 in Molecular Nutrition & Food Research
Verified
Journal Article
Open access
RWRen Wang
Ren Wang
SGSusan Goruk
Susan Goruk
Catherine ChanCatherine Chan
Catherine Chan
CFCatherine Field
Catherine Field
To investigate whether early‐life docosahexaenoic acid (DHA) consumption mitigated the effects of a high‐fat diet (HFD) on body composition, endocrine hormones, immune function, inflammatory biomarkers, and identify sex differences. Wistar rats were fed (PND 0–70) diets differing only in fat composition: control low‐fat (10% fat, 0% arachidonic acid [ARA], 0% DHA), control high‐fat (HF, 20% fat, 0% ARA, 0% DHA), or DHA HF (20% fat, 1% ARA, 2% DHA) ( n = 16/group, males/females = 8/8). Plasma hormones (ELISA), inflammatory biomarkers (electrochemiluminescence), splenocytes phenotype (immunofluorescence), and ex vivo cytokine production (ELISA) after mitogen stimulation were measured. HFD did not alter body weight/composition or inflammatory profile but increased plasma glucagon‐like peptide 1 (GLP‐1, males, p = 0.02). In the spleen, HFD lowered transforming growth factor‐beta (TGF‐β) and increased interleukin (IL)‐10 (females) and IL‐2 production ( p < 0.03). It also lowered % of regulatory T cells (Treg), B cells (males), conventional type 1dendritic cells (cDC1), and MHC‐II and CD86 expression (males) ( p < 0.03). DHA mitigated HFD‐related changes in plasma GLP‐1 (males) andTGF‐β, IL‐10 (females), and IL‐2 production ( p ≤ 0.03) and increased % of B cells (males), cDC1, MHC‐II, and CD86 expression (males) ( p < 0.03). DHA mitigated HFD‐induced impaired Treg response and compromised adaptive immunity and antigen‐presenting function in a sex‐specific manner.